Analysis of vitamin D analog-induced heterodimerization of vitamin D receptor with retinoid X receptor using the yeast two-hybrid system

Molecular Endocrinology

Volumn 11, Issue 3, 1997, Pages 366-378

  Zhao, Xiao Yan ^a   Eccleshall, T Ross ^a   Krishnan, Aruna V ^a   Gross, Coleman ^a   Feldman, David ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLECALCIFEROL DERIVATIVE; RETINOID X RECEPTOR; VITAMIN D; VITAMIN D RECEPTOR;

ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; HORMONE RECEPTOR INTERACTION; NONHUMAN; PRIORITY JOURNAL; VITAMIN D METABOLISM; YEAST;

EID: 0031049729     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.11.3.9895     Document Type: Article

References (45)

1. Norman AW, Roth J, Orci L 1982 The vitamin D endocrine system: steroid metabolism, hormone receptors, and biological response (calcium binding proteins). Endocr Rev 3:331-366
2. Holick MF (eds) 1989 Vitamin D: Biosynthesis, Metabolism, and Mode of Action. Grune and Stratton, New York
3. Feldman D, Malloy PJ, Gross C 1996 Vitamin D: metabolism and action. In: Marcus R, Feldman D, Kelsey J (eds) Osteoporosis. Academic Press, San Diego, pp 205-235
4. Suda T, Miyaura C, Abe E, Kuroki T 1986 Modulation of cell differentiation, immune response and tumor promotion by vitamin D compounds. In: Peck W (ed) Bone and Mineral Research. Elsevier, Amsterdam, vol 4:1-49
5. Pols HAP, Birkenhager JC, Foekens JA, Van Leeuwen JPTM 1990 Vitamin D: a modulator of cell proliferation and differentiation. J Steroid Biochem 37:873-876
6. Lemire JM 1992 Immunomodulatory role of 1,25-dihydroxyvitamin D3. J Cell Biochem 49:26-31
7. Abe J, Morikawa M, Miyamoto K, Kaiho S-I, Fukushima M, Miyaura C, Age E, Suda T, Nishi Y 1987 Synthetic analogues of vitamin D compounds with an oxygen atom in the side chain. FEBS Lett 226:58-62
8. Binderup L, Bramm E 1988 Effects of a novel vitamin D analogue MC-903 on cell proliferation and differentiation in vitro and on calcium metabolism in vivo. Biochem Pharmacol 37:889-895
9. Brown AJ, Finch JL, Lopez-Hilker S, Dusso A, Ritter C, Pernalete N, Slatopolsky E 1990 New active analogues of vitamin D with low calcemic activity. Kidney Int 38:S22-S27
10. Kissmeyer A-M, Binderup L 1991 Calcipotriol (MC 903): pharmacokinetics in rats and biological activities of metabolites. Biochem Pharmacol 41:1601-1606
11. Bikle DD 1992 Clinical counterpoint: vitamin D: new actions, new analogs, new therapeutic potential. Endocr Rev 13:765-784
12. Anzano MA, Smith JM, Uskokovic MR, Peer CW, Mullen LT, Letterio JJ, Welsh MC, Shrader MW, Logsdon DI, Driver CL, Brown CC, Roberts AR, Sporn MB 1994 1α,25-Dihydroxy-16-ene-23yne-26,27-hexafluorocholecalciferol (Ro24-5531) a new deltanoid (vitamin D analogue) for prevention of breast cancer in the rat. Cancer Res 54:1653-1656
13. 3 is due to reduced catabolism and altered protein binding. Biochem Pharmacol 47:987-993
14. Brown AJ, Dusso A, Slatopolsky E 1994 Selective vitamin D analogs and their therapeutic applications. Semin Nephrol 14:156-174
15. Ferrara J, McCuaig K, Hendy GM, Uskokovic M, White JH 1994 Highly potent transcriptional activation by 16-ene derivatives of 1,25-dihydroxyvitamin D3. J Biol Chem 269:2971-2981
16. Sasaki H, Harada H, Handa Y, Morino H, Suzawa M, Shimpo E, Katsumata T, Masuhiro Y, Matsuda K, Ebihara K, Ono T, Masushige S, Kato S 1995 Transcriptional activity of a fluorinated vitamin D analog on VDR-RXR-mediated gene expression. Biochemistry 34:370-377
17. Imai Y, Pike JW, Koeffler HP 1995 Potent vitamin D3 analogs: their abilities to enhance transactivation and to bind to the vitamin D response element. Leukocyte Res 19:147-158
18. 3. Mol Endocrinol 9:1814-1824
19. Evans RM 1988 The steroid and thyroid hormone receptor superfamily. Science 240:889-895
20. Mangelsdorf DJ, Thummel C, Miguel B, Herrlich P, Schutz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, Evans RM 1995 The nuclear receptor superfamily: the second decade. Cell 83:835-839
21. 3-modulated heterodimer. J Biol Chem 266:23296-23305
22. Yu VC, Delsert C, Andersen B, Holloway JM, Devary OV, Naar AM, Kim SY, Boutin JM, Glass CK, Rosenfeld MG 1991 RXR beta: a coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements. Cell 67:1251-1266
23. Kliewer SA, Umesono K, Mangelsdorf DJ, Evans RM 1992 Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signalling. Nature 355:446-449
24. Forman BM, Yang CR, Au M, Casanova J, Ghysdael J, Samuels HH 1989 A domain containing leucine-zipper-like motifs mediate novel in vivo interactions between the thyroid hormone and retinoic acid receptors. Mol Endocrinol 3:1610-1626
25. Nakajima S, Hsieh JC, MacDonald PN, Galligan MA, Haussler CA, Whitfield GK, Haussler MR 1994 The C-terminal region of the vitamin D receptor is essential to form a complex with a receptor auxiliary factor required for high affinity binding to the vitamin D-responsive element. Mol Endocrinol 8:159-172
26. Pike JW 1991 Vitamin D3 receptor: structure and function in transcription. Annu Rev Nutr 11:189-216
27. 3 are associated with enhanced activation of the vitamin D receptor. J Biol Chem 270:10551-10558
28. Fields S, Song OK 1989 A novel genetic system to detect protein-protein interactions. Nature 340:245-246
29. Estojak J, Brent R, Golemis EA 1995 Correlation of two-hybrid affinity data with in vitro measurements. Mol Cell Biol 15:5820-5829
30. Malloy PJ, Weisman Y, Feldman D 1994 Hereditary 1α,25-dihydroxyvitamin D-resistant rickets resulting from a mutation in the vitamin D receptor deoxyribonucleic acid-binding domain. J Clin Endocrinol Metab 78:313-316
31. Ozono K, Liao J, Kerner SA, Scott RA, Pike JW 1990 The vitamin D-responsive element in the human osteocalcin gene. Association with a nuclear proto-oncogene enhancer. J Biol Chem 265:21881-21888
32. 3. Endocrinology 136:20-26
33. Bouillon R, Okamura WH, Norman AW 1995 Structure-function relationships in the vitamin D endocrine system. Endocr Rev 16:200-256
34. 3 is due to reduced catabolism and altered protein binding. Biochem Pharmacol 47:987-993
35. Jin CH, Pike JW 1996 Human vitamin D receptor-dependent transactivation in Saccharomyces cerevisiae requires retinoid X receptor. Mol Endocrinol 10:196-205
36. Schena M, Yamamoto KR 1988 Mammalian glucocorticoid receptor derivatives enhance transcription in yeast. Science 241:965-967
37. Metzger D, White JH, Chambon P 1988 The human oestrogen receptor functions in yeast. Nature 334:31-36
38. Tasset D, Tora L, Fromental C, Scheer E, Chambon P 1990 Distinct classes of transcriptional activating domains function by different mechanisms. Cell 62:1177-1187
39. Tzukerman MT, Esty A, Santiso-Mere D, Danielian P, Parker MG, Stein RB, Pike JW, McDonnell DP 1994 Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions. Mol Endocrinol 8:21-30
40. Maniatis T, Fritsch EF, Sambrook J (eds) 1989 Molecular Cloning: A Laboratory Manual, ed 2. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
41. Burton K 1956 A study of conditions and mechanisms of the diphenyl amine colorimetric estimation of deoxyribonucleic acid. Biochem J 62:315-323
42. Bradford MM 1976 A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 72:248-254
43. Malloy PJ, Hochberg Z, Pike JW, Feldman D 1989 Abnormal binding of vitamin D receptors to deoxyribonucleic acid in a kindred with vitamin D-dependent ricketts, type II. J Clin Endocrinol Metab 68:263-269
44. Hill J, Ian KA, Donald G, Griffiths DE 1991 DMSO-enhanced whole cell yeast transformation. Nucleic Acids Res 19:5791
45. Sherman F, Fink GR, Hicks JB (eds) 1986 Laboratory Course Manual for Methods in Yeast Genetics. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY